GR3029580T3 - Vaccine comprising a sub-unit of the human transferrrin receptor from Neisseria meningitidis - Google Patents

Vaccine comprising a sub-unit of the human transferrrin receptor from Neisseria meningitidis

Info

Publication number
GR3029580T3
GR3029580T3 GR990400664T GR990400664T GR3029580T3 GR 3029580 T3 GR3029580 T3 GR 3029580T3 GR 990400664 T GR990400664 T GR 990400664T GR 990400664 T GR990400664 T GR 990400664T GR 3029580 T3 GR3029580 T3 GR 3029580T3
Authority
GR
Greece
Prior art keywords
pct
receptor
human
transferrrin
vaccine
Prior art date
Application number
GR990400664T
Other languages
Greek (el)
English (en)
Inventor
Marie-Jose Quentin-Millet
Ling Lissolo
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of GR3029580T3 publication Critical patent/GR3029580T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/871—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR990400664T 1991-10-03 1999-03-04 Vaccine comprising a sub-unit of the human transferrrin receptor from Neisseria meningitidis GR3029580T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9112176A FR2682114B1 (fr) 1991-10-03 1991-10-03 Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.
PCT/FR1992/000904 WO1993007172A1 (fr) 1991-10-03 1992-09-29 Vaccin de sous-unite contre les infections a neisseriameningitidis et sous-unites correspondantes a l'etat purifie

Publications (1)

Publication Number Publication Date
GR3029580T3 true GR3029580T3 (en) 1999-06-30

Family

ID=9417548

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990400664T GR3029580T3 (en) 1991-10-03 1999-03-04 Vaccine comprising a sub-unit of the human transferrrin receptor from Neisseria meningitidis

Country Status (15)

Country Link
US (2) US5618540A (de)
EP (1) EP0560969B1 (de)
JP (1) JPH06503364A (de)
AT (1) ATE174930T1 (de)
AU (1) AU668522B2 (de)
CA (1) CA2096411A1 (de)
DE (1) DE69227984T2 (de)
DK (1) DK0560969T3 (de)
ES (1) ES2128358T3 (de)
FI (1) FI107262B (de)
FR (1) FR2682114B1 (de)
GR (1) GR3029580T3 (de)
HU (1) HU219762B (de)
NO (1) NO309865B1 (de)
WO (1) WO1993007172A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
DE69418699T2 (de) * 1993-01-11 1999-09-30 Dana-Farber Cancer Institute, Boston Induktion der antworten zytotoxischer t-lymphozyten
ES2270420T3 (es) * 1993-11-08 2007-04-01 Sanofi Pasteur Limited Genes receptores de la transferrina de haemophilus.
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
US6290970B1 (en) * 1995-10-11 2001-09-18 Aventis Pasteur Limited Transferrin receptor protein of Moraxella
FR2785293B1 (fr) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
WO2000042193A1 (en) * 1999-01-15 2000-07-20 Smithkline Beecham Biologicals S.A. Neisseria meningitidis antigen
WO2010130898A2 (fr) 2009-05-14 2010-11-18 Sanofi Pasteur Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6
WO2011024072A2 (en) * 2009-08-27 2011-03-03 Novartis Ag Hybrid polypeptides including meningococcal fhbp sequences
CA2931685C (en) 2013-12-02 2021-09-07 Anthony B. Schryvers Immunogenic compositions and vaccines derived from bacterial surface receptor proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
DE69133334T2 (de) * 1990-08-23 2004-05-13 University Of North Carolina At Chapel Hill Transferrin bindende proteine aus neisseria-gonorrhoeae und neisseria-meningitidis
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.

Also Published As

Publication number Publication date
FR2682114B1 (fr) 1996-02-23
EP0560969A1 (de) 1993-09-22
ES2128358T3 (es) 1999-05-16
FI932490L (fi) 1993-06-01
CA2096411A1 (en) 1993-04-04
NO309865B1 (no) 2001-04-09
HUT69929A (en) 1995-09-28
US5618540A (en) 1997-04-08
WO1993007172A1 (fr) 1993-04-15
NO932009L (no) 1993-07-20
FI107262B (fi) 2001-06-29
NO932009D0 (no) 1993-06-02
AU668522B2 (en) 1996-05-09
HU9301631D0 (en) 1993-10-28
FI932490A0 (fi) 1993-06-01
US5928650A (en) 1999-07-27
DE69227984T2 (de) 1999-05-12
ATE174930T1 (de) 1999-01-15
AU2764092A (en) 1993-05-03
DK0560969T3 (da) 1999-08-23
HU219762B (hu) 2001-07-30
JPH06503364A (ja) 1994-04-14
DE69227984D1 (de) 1999-02-04
FR2682114A1 (fr) 1993-04-09
EP0560969B1 (de) 1998-12-23

Similar Documents

Publication Publication Date Title
HUT69980A (en) Vaccine for neisseria medingitidis infections
FI963398A0 (fi) Kielenalainen tai poskensisäinen farmaseuttinen koostumus
IS2034B (is) Ný lyfjablanda til inntöku um munn sem inniheldurnýtt magnesíumsalt ómeprasóls, aðferð við framleiðslu hennar og notkun
IL116083A (en) Liquid pharmaceutical compositions containing ondanseteron and sorbitol as sweetener
MX9802564A (es) Composiciones de dipeptidos angioestaticas farmaceuticas y metodos para usar las mismas.
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
HU9600592D0 (en) Preparation for substitution therapy, containing at least one progestogen and at least one extrogen
IL108520A0 (en) Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
AU3254395A (en) Use of a combination product that contains a competitive progesterone antagonist and a gestagen for the production of a pharmaceutical agent for treating endometriosis or leiomyomata uteri
GB9408775D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
HU9301631D0 (en) Sub-unit vaccine against neisseria meningitidis infections and corresponding purified sub-units
GB9424766D0 (en) Pharmaceutical composition
GR3022615T3 (en) Pharmaceutical compositions based on ebastime or analogues thereof.
IL84844A0 (en) Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof
IL133632A (en) Use of a specific 5ht2 receptor antagonist for the preparation of pharmaceutical compositions useful in the treatment of the sleep apnea syndrome
IL108750A (en) Pharmaceutical cognition enhancing compositions containing 1,3-dialiphatic-8-(phenylalkyl or ludanyl) xanthines as selective adenosine receptor agents
IL112999A0 (en) Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing them
FR2724933B1 (de)
GB9015774D0 (en) Novel treatment